AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial-Reference-Cited by-同舟云学术

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

Published:2013-06 Issue:6 Volume:13 Page:485-496
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

McElhaney Janet E,Beran Jiri,Devaster Jeanne-Marie,Esen Meral,Launay Odile,Leroux-Roels Geert,Ruiz-Palacios Guillermo M,van Essen Gerrit A,Caplanusi Adrian,Claeys Carine,Durand Christelle,Duval Xavier,El Idrissi Mohamed,Falsey Ann R,Feldman Gregory,Frey Sharon E,Galtier Florence,Hwang Shinn-Jang,Innis Bruce L,Kovac Martina,Kremsner Peter,McNeil Shelly,Nowakowski Andrzej,Richardus Jan Hendrik,Trofa Andrew,Oostvogels Lidia

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference31 articles.

1. Influenza-associated hospitalizations in the United States;Thompson;JAMA,2004

2. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

3. Effectiveness of influenza vaccine in the community-dwelling elderly;Nichol;N Engl J Med,2007

4. Vaccines for preventing influenza in healthy adults;Demicheli;Cochrane Database Syst Rev,2007

5. Vaccines for preventing influenza in the elderly;Rivetti;Cochrane Database Syst Rev,2006

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectious Disease Updates for Primary Care;Medical Clinics of North America;2024-09

2. A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age;The Journal of Infectious Diseases;2023-12-29

3. High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update;Vaccine: X;2023-08

4. Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations;Frontiers in Immunology;2023-06-27

5. Adjuvants for COVID-19 Vaccines;Vaccines;2023-04-26